Joint Formulary & PAD

Ambrisentan - Pulmonary arterial hypertension

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Associated Icons :
BNF SPC
NFD1
NHSE
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Ambrisentan
Indication :
Pulmonary arterial hypertension
Group Name :
Keywords :
PAH
Brand Names Include :
Volibris
Important Information :

NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Ambrisentan is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Pulmonary arterial hypertension.

Committee Recommendations (0)

  • No records returned.